Cutaneous Adverse
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Association Between Drug-related Cutaneous Adverse Events and Progression Free Survival in Patients Treated with Enfortumab Vedotin (NCT06682845) | Hospices Civils de Lyon | 2024-05-02 |
Track Cutaneous Adverse automatically
Every clearance here is in the API, with alerts when new ones post.